Report on shares re-lodged for transfer cum Demat of Physical shares.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals has submitted a routine compliance report to BSE regarding the SEBI-mandated special window for re-lodging physical share transfer requests. The report, prepared by the company's Registrar & Transfer Agent (Venture Capital and Corporate Investments), covers the status as of January 6, 2026. No transfer requests were received, processed, approved, or rejected during the month — the entire table reads NIL. This is a procedural filing with no underlying transaction activity to disclose.
No impact on shareholders or the stock price. This is a standard nil-report compliance filing with no financial or operational implications.